Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy

Brachytherapy

Volumn 8, Issue 3, 2009, Pages 284-289

  Grimard, Laval ^a   Esche, Bernd ^a   Lamothe, André ^b   Spaans, Johanna N ^c  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Brachytherapy; Cancer; Head and neck; Persistent

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CAROTID ARTERY SURGERY; CELLULITIS; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FISTULA; HEAD AND NECK CANCER; HUMAN; INTERSTITIAL RADIATION; LARYNGECTOMY; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION NECROSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WOUND DEHISCENCE;

ADULT; AGED; BRACHYTHERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 67651008288     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.12.007     Document Type: Article

References (24)

1. American Cancer Society, Surveillance Research, Facts & Figures, 2004.
2. Garg M., and Beitler J.J. Controversies in management of the neck in head and neck cancer. Curr Treat Options Oncol 5 (2004) 35-40
3. Fu K.K., Pajak T.F., Trotti A., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324 (1991) 1685-1690
5. Looser K.G., Shah J.P., and Strong E.W. The significance of "positive" margins in surgically resected epidermoid carcinoma. Head Neck Surg 1 (1978) 107-111
6. Barkley H.T., and Fletcher G.H. The significance of residual disease after external irradiation of squamous cell carcinoma of the oropharynx. Radiology 124 (1977) 493-495
7. Katsuno S., Takemae T., Ishiyam T., et al. Is carotid reconstruction for advanced cancer in the neck a safe procedure?. Otolaryngology 124 (2001) 222-224
8. Freeman S.B., Hamaker R.C., Borrowdale R.B., et al. Management of neck metastasis with carotid artery involvement. Laryngoscope 114 (2004) 20-24
9. Choy D., Sham J.S.T., Wei W.I., et al. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 505-512
10. Sham J.S.T., Wei W.I., Choy D., et al. Treatment of persistent and recurrent nasopharyngeal carcinoma by brachytherapy. Br J Radiol 62 (1989) 355-361
11. Glatzel M., Buntzel J., Schoder D., et al. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck disease. Laryngoscope 112 (2002) 1366-1371
12. Chua D.T., Wei W.I., Sham J.S., et al. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma. Head Neck 25 (2003) 585-594
13. Syed A.M., Puthawala A.A., Damore S.J., et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 47 (2000) 1311-1321
14. Grimard L., Esche B., Lamothe A., et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck 28 (2006) 888-895
15. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
17. Cox D.R. Regression models and life tables. J R Stat Soc Ser 34B (1972) 187-202
18. Farias T.P., Dias F.L., Lima R.A., et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 129 (2003) 794-799
19. Marcial V.A., Hanley J.A., Chang C., et al. Split-course radiation therapy of carcinoma of the nasopharynx: Results of a national collaborative clinical trial of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6 (1980) 409-414
20. Heng D.M., Wee J., Fong K.W., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86 (1999) 1912-1920
21. Kwong D.L., Nicholls J., Wei W.I., et al. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma. Cancer 85 (1999) 1446-1453
22. Kaylie D.M., Stevens K.R., Kang M.Y., et al. External beam radiation followed by planned neck dissection and brachytherapy for base of tongue squamous cell carcinoma. Laryngoscope 110 (2000) 1633-1636
23. Narayana A., Cohen G.N., Zaider M., et al. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers-Preliminary results. Brachytherapy 6 (2007) 157-163
24. Yau T.K., Sze W.M., Lee W.M., et al. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Head Neck 26 (2004) 1024-1030